Unity Biotechnology (UNBX) Total Assets by Year
Unity Biotechnology Inc closed fiscal year 2024 with $37.7M in total assets, $31.2M in total liabilities and $6.5M in shareholder equity. Total assets fell 42.7% from the prior fiscal year. The table below carries 9 fiscal years, from 2016 to 2024, and the quarters Unity Biotechnology Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
UNBX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing | FY17Filing | FY16Filing |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $37.7M-42.7% | $65.7M-47.2% | $124.3M-0.3% | $124.7M-20.2% | $156.3M+3.4% | $151.2M-16.6% | $181.4M+77.8% | $102.0M | N/A |
| Total Liabilities | $31.2M-16.4% | $37.3M-45.4% | $68.3M+4.8% | $65.1M-11.3% | $73.4M+140.7% | $30.5M+47.5% | $20.7M-88.8% | $185.1M | N/A |
| Total Equity | $6.5M-77.1% | $28.4M-49.4% | $56.1M-5.9% | $59.6M-28.1% | $82.9M-31.3% | $120.7M-24.9% | $160.7Mn/m | -$83.1Mn/m | -$41.5M |
UNBX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing | Q3'23Filing | Q2'23Filing | Q1'23Filing | Q4'22Filing | Q3'22Filing | Q2'22Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.3M-48.4% | $37.7M-42.7% | $47.1M-32.0% | $53.5M-47.0% | $58.9M-48.5% | $65.7M-47.2% | $69.3M-49.2% | $101.0M+3.5% | $114.3M+1.6% | $124.3M-0.3% | $136.2M+8.4% | $97.6M-28.4% |
| Total Liabilities | $30.6M-12.4% | $31.2M-16.4% | $33.0M-20.6% | $33.8M-43.9% | $34.9M-42.7% | $37.3M-45.4% | $41.5M-44.7% | $60.2M+4.5% | $60.9M-1.4% | $68.3M+4.8% | $75.2M+10.6% | $57.7M-18.0% |
| Total Equity | -$205K-100.9% | $6.5M-77.1% | $14.1M-49.0% | $19.8M-51.5% | $24.0M-55.0% | $28.4M-49.4% | $27.7M-54.6% | $40.8M+2.1% | $53.4M+5.3% | $56.1M-5.9% | $61.1M+5.7% | $39.9M-39.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Unity Biotechnology Inc financials
Frequently Asked Questions
Unity Biotechnology Inc closed fiscal year 2024 with $37.7M in total assets, $31.2M in total liabilities and $6.5M in shareholder equity.
Unity Biotechnology Inc (UNBX) total assets fell by 42.7% year over year, from $65.7M to $37.7M in fiscal year 2024.
Unity Biotechnology Inc (UNBX) reported $30.3M in total assets in Q1 2025. This represents a decrease of 48.4% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Unity Biotechnology Inc (UNBX) reported on that line in every period on record.